Septerna, Inc. reported $99M of revenue over the trailing twelve months, +13520% on the year before. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $99M (to Q2 2026). Net income: −$24M, trailing twelve months to Q2 2026. Free cash flow: $105M, trailing twelve months to Q2 2026. Operating margin: −42%, trailing twelve months to Q2 2026.

SEPNSepterna, Inc.

Healthcare

$38.32+144% 1Y

$38.32

$16.0052 weeks$48.13

SEPN as reported

Septerna, Inc. reported $99M of revenue over the trailing twelve months, +13520% on the year before. 8 reported series are charted on this page, each one as filed.

$99M

Revenue, trailing twelve months · to Q2 2026 · +13520% against the twelve months before

Net income: −$24M
Net income · −72% year on year · trailing twelve months to Q2 2026
Free cash flow: $105M
Free cash flow · −227% year on year · trailing twelve months to Q2 2026
Operating margin: −42%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SEPN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$99M	+13520%	Q2 2026
Net income	−$24M	−72%	Q2 2026
EPS	−$0.54	−110%	Q2 2026
Operating margin	−42%	n/a	Q2 2026
Net margin	−22%	n/a	Q2 2026
ROE	−11%	n/a	Q2 2026
ROA	−7.1%	n/a	Q2 2026
Free cash flow	$105M	−227%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.